Healthcare · Drug Manufacturers - Specialty & Generic
Rockwell Medical, Inc. , together with its associated companies, operates as a biopharmaceutical firm specializing in treatments for chronic and end-stage kidney disease.
52W Range
23rdpctl
Volume
1.18×avg
Market Cap
32.25MUSD
P/E Ratio
-5.9TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Rockwell Medical, Inc.
RMTINASDAQ Capital Market·USD·Closed
Rockwell Medical, Inc.
RMTINASDAQ·USD·Closed
$8.17
+5.42%
$8.17
+$0.42 (5.42%)
52W Range
23rdpctl
Volume
1.18×avg
Mkt Cap
32.25MUSD
P/E
-5.9TTM
Div Yield
–ann
RMTI: Rockwell Medical, Inc. Stock Analysis | finqOS
